Education
About Us
Working with TipRanks
Follow Us
Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
Total Valuation
Abivax SA Sponsored ADR has a market cap or net worth of $450.95M. The enterprise value is $412.58M.
Market Cap$450.95M
Enterprise Value$412.58M
Share Statistics
Abivax SA Sponsored ADR has 63,418,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,418,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Abivax SA Sponsored ADR’s return on equity (ROE) is -0.75 and return on invested capital (ROIC) is -46.19%.
Return on Equity (ROE)-0.75
Return on Assets (ROA)-0.45
Return on Invested Capital (ROIC)-46.19%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee66.97K
Profits Per Employee-2.14M
Employee Count69
Asset Turnover0.01
Inventory Turnover-0.12
Valuation Ratios
The current PE Ratio of Abivax SA Sponsored ADR is -2.82. Abivax SA Sponsored ADR’s PEG ratio is -0.29.
PE Ratio-2.82
PS Ratio0.00
PB Ratio2.13
Price to Fair Value2.13
Price to FCF-4.16
Price to Operating Cash Flow-4.17
PEG Ratio-0.29
Income Statement
In the last 12 months, Abivax SA Sponsored ADR had revenue of 4.62M and earned -147.74M in profits. Earnings per share was -3.43.
Revenue4.62M
Gross Profit3.91M
Operating Income-127.38M
Pretax Income-152.23M
Net Income-147.74M
EBITDA-133.21M
Earnings Per Share (EPS)-3.43
Cash Flow
In the last 12 months, operating cash flow was -100.01M and capital expenditures -266.00K, giving a free cash flow of -100.28M billion.
Operating Cash Flow-100.01M
Free Cash Flow-100.28M
Free Cash Flow per Share-1.58
Dividends & Yields
Abivax SA Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change-51.90%
50-Day Moving Average6.64
200-Day Moving Average8.68
Relative Strength Index (RSI)53.25
Average Volume (3m)137.07K
Important Dates
Abivax SA Sponsored ADR upcoming earnings date is Jun 2, 2025, TBA Not Confirmed.
Last Earnings DateMar 24, 2025
Next Earnings DateJun 2, 2025
Ex-Dividend Date―
Financial Position
Abivax SA Sponsored ADR as a current ratio of 4.08, with Debt / Equity ratio of 239.90%
Current Ratio4.08
Quick Ratio4.17
Debt to Market Cap0.13
Net Debt to EBITDA1.47
Interest Coverage Ratio-8.05
Taxes
In the past 12 months, Abivax SA Sponsored ADR has paid -4.49M in taxes.
Income Tax-4.49M
Effective Tax Rate0.03
Enterprise Valuation
Abivax SA Sponsored ADR EV to EBITDA ratio is -1.65, with an EV/FCF ratio of -2.20.
EV to Sales47.70
EV to EBITDA-1.65
EV to Free Cash Flow-2.20
EV to Operating Cash Flow-2.20
Balance Sheet
Abivax SA Sponsored ADR has $260.99M in cash and marketable securities with €55.46M in debt, giving a net cash position of -$205.53M billion.
Cash & Marketable Securities$260.99M
Total Debt€55.46M
Net Cash-$205.53M
Net Cash Per Share-$3.24
Tangible Book Value Per Share$3.97
Margins
Gross margin is 84.70%, with operating margin of -2756.46%, and net profit margin of -3197.14%.
Gross Margin84.70%
Operating Margin-2756.46%
Pretax Margin-3294.37%
Net Profit Margin-3197.14%
EBITDA Margin-2882.64%
EBIT Margin-2897.94%
Analyst Forecast
The average price target for Abivax SA Sponsored ADR is $35.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$35.00
Price Target Upside421.61% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast18.47%